Device Knees

Osseoti Reconstructive System

Payments companies reported to CMS as associated with Osseoti Reconstructive System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$7,942associated payments (2023-2025)
74clinicians with associated payments
1company reporting

By year

2023 $1,094
2024 $4,401
2025 $2,447

Payments reported as associated with Osseoti Reconstructive System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $4,794
Adult Reconstructive Orthopaedic Surgery $1,473
Physician Assistant $501
Surgical $281
Sports Medicine (Orthopaedic Surgery) $231
Orthopaedic Trauma $169

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Osseoti Reconstructive System

These are the largest totals companies reported as associated with Osseoti Reconstructive System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Qais Naziri Brooklyn, NY Orthopaedic Surgery $435.41
Sean Childs Geneva, NY Orthopaedic Surgery $232.81
Jason Lipof Stanford, CA Adult Reconstructive Orthopaedic Surgery $232.80
Leonard Kolodychuk Bellingham, WA Orthopaedic Surgery $199.08
James Holstine Bellingham, WA Orthopaedic Surgery $199.08
Jeffrey Stimac Louisville, KY Orthopaedic Surgery $191.14
James Baker Louisville, KY Adult Reconstructive Orthopaedic Surgery $191.13
Robert Carangelo Plainville, CT Orthopaedic Surgery $189.51
Daniel Witmer Farmington, CT Orthopaedic Surgery $189.51
Jeffrey Burns Hartford, CT Adult Reconstructive Orthopaedic Surgery $189.51

Prescribed Osseoti Reconstructive System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.